Evidence map›Paper›PMID 39256571›Full record

ArticleNature neuroscience2024

VEGF-A-mediated venous endothelial cell proliferation results in neoangiogenesis during neuroinflammation.

Sanjid Shahriar, Saptarshi Biswas, Kaitao Zhao, Uğur Akcan, Mary Claire Tuohy, Michael D Glendinning, Ali Kurt, Charlotte R Wayne, Grace Prochilo, Maxwell Z Price and 4 more

Abstract read
PubMed Publisher
In one paragraph

Article in Nature neuroscience, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. New perspectives on VEGF signalling in Alzheimer's disease.Brain pathology (Zurich, Switzerland) · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Expanding roles of cGAS-STING signaling in neuroinflammation.The Journal of clinical investigation · 2026
    Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Sanjid Shahriar *Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, NY, USA.ORCID http://orcid.org/0000-0003-4911-9742
Saptarshi Biswas *Department of Neurology, Columbia University Irving Medical Center, New York, NY, USA.
Kaitao ZhaoDepartment of Neurology, Columbia University Irving Medical Center, New York, NY, USA.
Uğur AkcanDepartment of Neurology, Columbia University Irving Medical Center, New York, NY, USA.
Mary Claire TuohyDepartment of Neurology, Columbia University Irving Medical Center, New York, NY, USA.ORCID http://orcid.org/0000-0003-0600-9834
Michael D GlendinningDepartment of Neurology, Columbia University Irving Medical Center, New York, NY, USA.
Ali KurtDepartment of Neurology, Columbia University Irving Medical Center, New York, NY, USA.
Charlotte R WayneDepartment of Neurology, Columbia University Irving Medical Center, New York, NY, USA.
Grace ProchiloDepartment of Biological Sciences, Columbia University, New York, NY, USA.
Maxwell Z PriceDepartment of Biological Sciences, Columbia University, New York, NY, USA.ORCID http://orcid.org/0000-0001-7480-7008
Heidi StuhlmannDepartment of Cell and Developmental Biology, Weill Cornell Medical College, New York, NY, USA.ORCID http://orcid.org/0000-0001-7217-768X
Rolf A BrekkenDepartment of Surgery, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Vilas MenonDepartment of Neurology, Columbia University Irving Medical Center, New York, NY, USA.ORCID http://orcid.org/0000-0002-4096-8601
Dritan AgalliuDepartment of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, NY, USA. da191@cumc.columbia.edu.ORCID http://orcid.org/0000-0002-5375-4143

Funding

Tumor Biology and Microenvironment ProgramP30CA013696 · NCI · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI Anil K Rustgi · 1985 to 2026
$115.3M
ADVANCED GRADUATE TRAINING PROGRAM IN NEUROBIOLOGY & BEHAVIORT32NS064928 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI HENGST, ULRICH · 2010 to 2024
$3.0M
Neuronal Regulation of Vascular Development and Maturation in the RetinaR01EY033994 · NEI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Dritan Agalliu · 2022 to 2026
$2.3M
Assessing the effects of peripheral immune activation on the NVU following TBI using a vascularized and perfused human blood/BBB modelR33HL159949 · NHLBI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI AGALLIU, DRITAN, LIS, RAPHAEL · 2023 to 2025
$2.2M
Cellular and humoral immune mechanisms underlying neurovascular dysfunction in autoimmune encephalitisR01MH112849 · NIMH · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI AGALLIU, DRITAN, CUTFORTH, TYLER · 2017 to 2020
$2.1M
Assessing the effects of peripheral immune activation on the NVU following TBI using avascularized and perfused human blood/BBB model.R61HL159949 · NHLBI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI AGALLIU, DRITAN, LIS, RAPHAEL · 2021 to 2022
$1.9M
Elucidating the role of RXRA in the myeloid lineage in post-infectious basal ganglia encephalitisR21NS130265 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI AGALLIU, DRITAN · 2022 to 2022
$442k
The role of autophagy in the neurovascular unit for the physiological response to stress.R21NS118891 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI AGALLIU, DRITAN, YAMAMOTO, AI · 2020 to 2020
$438k
National Multiple Sclerosis Society (National MS Society) RG-1901-33218NEI NIH HHS R01 EY033994NHLBI NIH HHS R33 HL159949NHLBI NIH HHS R61 HL159949NIMH NIH HHS R01 MH112849NINDS NIH HHS R21 NS118891NINDS NIH HHS R21 NS130265NINDS NIH HHS T32 NS064928U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI) R61HL159949U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NINDS) R21NS130265U.S. Department of Health & Human Services | NIH | NCI | Division of Cancer Epidemiology and Genetics, National Cancer Institute (National Cancer Institute Division of Cancer Epidemiology and Genetics) P30CA013696
6 · The paper itself

Abstract

Newly formed leaky vessels and blood-brain barrier (BBB) damage are present in demyelinating acute and chronic lesions in multiple sclerosis (MS) and experimental autoimmune encephalomyelitis (EAE). However, the endothelial cell subtypes and signaling pathways contributing to these leaky neovessels are unclear. Here, using single-cell transcriptional profiling and in vivo validation studies, we show that venous endothelial cells express neoangiogenesis gene signatures and show increased proliferation resulting in enlarged veins and higher venous coverage in acute and chronic EAE lesions in female adult mice. These changes correlate with the upregulation of vascular endothelial growth factor A (VEGF-A) signaling. We also confirmed increased expression of neoangiogenic markers in acute and chronic human MS lesions. Treatment with a VEGF-A blocking antibody diminishes the neoangiogenic transcriptomic signatures and vascular proliferation in female adult mice with EAE, but it does not restore BBB function or ameliorate EAE pathology. Our data demonstrate that venous endothelial cells contribute to neoangiogenesis in demyelinating neuroinflammatory conditions.

Indexed as

Cell ProliferationEncephalomyelitis, Autoimmune, ExperimentalEndothelial CellsNeovascularization, PathologicVascular Endothelial Growth Factor AAnimalsBlood-Brain BarrierFemaleHumansMiceMice, Inbred C57BLMultiple SclerosisNeuroinflammatory DiseasesVascular Endothelial Growth Factor A

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.